The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer’s disease treatment.
© 2020-23 Digest Wire. All rights belong to their respective owners.
Tuesday, October 29, 2024
Biogen to cease production of controversial Alzheimer’s drug
ADVERTISEMENT
Trending
Shimron Hetmyer named in West Indies ODI squad to face England
Alick Athanaze dropped in only change to squad that lost 2-1 in Sri Lanka
DigestWire is an automated news feed that utilizes AI technology to gather information from sources with varying perspectives. This allows users to gain a comprehensive understanding of different arguments and make informed decisions. DigestWire is dedicated to serving the public interest and upholding democratic values.
Privacy Policy Terms and Conditions